• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以5-苯基咪唑/高氯酸盐体系为配体的一系列铜(II)配合物中的溶剂同构现象。

Solvatomorphism in a series of copper(II) complexes with the 5-phenylimidazole/perchlorate system as ligands.

作者信息

Loukopoulos Edward, Papatriantafyllopoulou Constantina, Moushi Eleni, Kitos Alexandros A, Tasiopoulos Anastasios J, Perlepes Spyros P, Nastopoulos Vassilios

机构信息

Department of Chemistry, University of Patras, Patras, 26504, Greece.

Department of Chemistry, University of Cyprus, Nicosia, 1678, Cyprus.

出版信息

Acta Crystallogr B Struct Sci Cryst Eng Mater. 2024 Aug 1;80(Pt 4):347-359. doi: 10.1107/S2052520624005948. Epub 2024 Jul 30.

DOI:10.1107/S2052520624005948
PMID:39136540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11301897/
Abstract

In the course of an investigation of the supramolecular behaviour of copper(II) complexes with the 5-phenylimidazole/perchlorate ligand system (`blend') remarkable solvatomorphism has been observed. By employing a variety of crystallization solvents (polar protic, polar/non-polar aprotic), a series of 12 crystalline solvatomorphs with the general formula [Cu(ClO)(LH)]·x(solvent) have been obtained [LH = 5-phenylimidazole, x(solvent) = 3.3(HO) (1), 2(methanol) (2), 2(ethanol) (3), 2(1-propanol) (4), 2(2-propanol) (5), 2(2-butanol) (6), 2(dimethylformamide) (7), 2(acetone) (8), 2(tetrahydrofurane) (9), 2(1,4-dioxane) (10), 2(ethyl acetate) (11) and 1(diethyl ether) (12)]. The structures have been solved using single-crystal X-ray diffraction and the complexes were characterized by thermal analysis and infrared spectroscopy. The solvatomorphs are isostructural (triclinic, P1), with the exception of compound 9 (monoclinic, P2/n). The supramolecular structures and the role of the various solvents is discussed. All potential hydrogen-bond functionalities, both of the [Cu(ClO)(LH)] units and of the solvents, are utilized in the course of the crystallization process. The supramolecular assembly in all structures is directed by strong recurring N-H...O motifs leading to robust scaffolds composed of the [Cu(ClO)(LH)] host complexes. The solvents are located in channels and, with the exception of the disordered waters in 1 and the diethyl ether in 12, participate in hydrogen-bonding formation with the [Cu(ClO)(LH)] complexes, serving as both hydrogen-bond acceptors and donors (for the polar protic solvents in 2-6), or solely as hydrogen-bond acceptors (for the polar/non-polar aprotic solvents in 7-11), linking the complexes and contributing to the stability of the crystalline compounds.

摘要

在对铜(II)与5-苯基咪唑/高氯酸盐配体体系(“混合物”)的超分子行为进行研究的过程中,观察到了显著的溶剂同构现象。通过使用多种结晶溶剂(极性质子溶剂、极性/非极性非质子溶剂),获得了一系列通式为[Cu(ClO)(LH)]·x(溶剂)的12种晶体溶剂同构体[LH = 5-苯基咪唑,x(溶剂)= 3.3(水)(1)、2(甲醇)(2)、2(乙醇)(3)、2(1-丙醇)(4)、2(2-丙醇)(5)、2(2-丁醇)(6)、2(二甲基甲酰胺)(7)、2(丙酮)(8)、2(四氢呋喃)(9)、2(1,4-二氧六环)(10)、2(乙酸乙酯)(11)和1(乙醚)(12)]。使用单晶X射线衍射解析了结构,并通过热分析和红外光谱对配合物进行了表征。除化合物9(单斜晶系,P2/n)外,溶剂同构体为同晶型(三斜晶系,P1)。讨论了超分子结构以及各种溶剂的作用。在结晶过程中,[Cu(ClO)(LH)]单元和溶剂的所有潜在氢键功能都得到了利用。所有结构中的超分子组装都由强烈重复出现的N-H...O基序引导,形成了由[Cu(ClO)(LH)]主体配合物组成的坚固支架。溶剂位于通道中,除了1中的无序水分子和12中的乙醚外,它们与[Cu(ClO)(LH)]配合物参与氢键形成,既作为氢键受体又作为氢键供体(对于2-6中的极性质子溶剂),或者仅作为氢键受体(对于7-11中的极性/非极性非质子溶剂),连接配合物并有助于晶体化合物的稳定性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1816/11301897/097658dc0458/b-80-00347-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1816/11301897/6ca9fd95422b/b-80-00347-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1816/11301897/5d84bfd41ea0/b-80-00347-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1816/11301897/a64f9cb563ac/b-80-00347-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1816/11301897/63c435e071fb/b-80-00347-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1816/11301897/db81b74482d6/b-80-00347-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1816/11301897/fde1ae7736ae/b-80-00347-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1816/11301897/aa91fcf3083f/b-80-00347-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1816/11301897/097658dc0458/b-80-00347-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1816/11301897/6ca9fd95422b/b-80-00347-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1816/11301897/5d84bfd41ea0/b-80-00347-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1816/11301897/a64f9cb563ac/b-80-00347-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1816/11301897/63c435e071fb/b-80-00347-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1816/11301897/db81b74482d6/b-80-00347-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1816/11301897/fde1ae7736ae/b-80-00347-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1816/11301897/aa91fcf3083f/b-80-00347-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1816/11301897/097658dc0458/b-80-00347-fig8.jpg

相似文献

1
Solvatomorphism in a series of copper(II) complexes with the 5-phenylimidazole/perchlorate system as ligands.以5-苯基咪唑/高氯酸盐体系为配体的一系列铜(II)配合物中的溶剂同构现象。
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2024 Aug 1;80(Pt 4):347-359. doi: 10.1107/S2052520624005948. Epub 2024 Jul 30.
2
Influence of ligand positional isomerism on the molecular and supramolecular structures of cobalt(II)-phenylimidazole complexes.配体位置异构对钴(II)-苯基咪唑配合物分子和超分子结构的影响。
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2019 Aug 1;75(Pt 4):599-610. doi: 10.1107/S205252061900636X. Epub 2019 Jun 14.
3
Isostructurality Among 5 Solvatomorphs of Betulin: X-Ray Structure and Characterization.桦木醇5种溶剂化物的同构性:X射线结构与表征
J Pharm Sci. 2016 Jun;105(6):1867-1873. doi: 10.1016/j.xphs.2016.03.015. Epub 2016 Apr 26.
4
Two solvatomorphic forms of a copper complex formulated as Cu(L(1))(ClO4)2·1.2H2O and Cu(L(1))(ClO4)2, where L(1) is 3,10-C-meso-3,5,7,7,10,12,14,14-octamethyl-1,4,8,11-tetraazacyclotetradecane.一种铜配合物的两种溶剂化变体,其化学式为Cu(L(1))(ClO4)2·1.2H2O和Cu(L(1))(ClO4)2,其中L(1)为3,10-C-内消旋-3,5,7,7,10,12,14,14-八甲基-1,4,8,11-四氮杂环十四烷。
Acta Crystallogr C. 2013 Jul;69(Pt 7):689-95. doi: 10.1107/S0108270113013711. Epub 2013 Jun 8.
5
Binding of nitrite and its reductive activation to nitric oxide at biomimetic copper centers.亚硝酸盐在仿生铜中心的结合及其向一氧化氮的还原活化。
J Biol Inorg Chem. 2000 Apr;5(2):251-61. doi: 10.1007/s007750050369.
6
Trinuclear N,N-bridged copper(II) complexes involving a Cu3OH core: [Cu3(mu 3-OH)L3A(H2O)2]A.(H2O)x (L = 3-acetylamino-1,2,4-triazolate; a = CF3SO3, NO3, ClO4; x = 0, 2) synthesis, X-ray structures, spectroscopy, and magnetic properties.含Cu3OH核的三核N,N桥连铜(II)配合物:[Cu3(μ3-OH)L3A(H2O)2]A·(H2O)x (L = 3-乙酰氨基-1,2,4-三唑酸根;A = CF3SO3、NO3、ClO4;x = 0、2)的合成、X射线结构、光谱及磁性
Inorg Chem. 2000 May 1;39(9):1859-67. doi: 10.1021/ic981393u.
7
Solvatomorphism of Moxidectin.莫昔克丁的溶剂化物形态。
Molecules. 2021 Aug 11;26(16):4869. doi: 10.3390/molecules26164869.
8
A rational design for imidazolate-bridged linear trinuclear compounds from mononuclear copper(II) complexes with 2-[((imidazol-2-ylmethylidene)amino)ethyl]pyridine (HL): syntheses, structures, and magnetic properties of [Cu(L)(hfac)M(hfac)2Cu(hfac)(L)] (M = ZnII, CuII, MnII).由单核铜(II)配合物与2-[((咪唑-2-基亚甲基)氨基)乙基]吡啶(HL)制备咪唑桥连线性三核化合物的合理设计:[Cu(L)(hfac)M(hfac)2Cu(hfac)(L)](M = ZnII、CuII、MnII)的合成、结构及磁性质
Inorg Chem. 2000 Jun 26;39(13):2770-6. doi: 10.1021/ic991401m.
9
Supramolecular hydrogen-bonded networks formed from copper(II) carboxylate dimers.由羧酸铜(II)二聚体形成的超分子氢键网络。
Acta Crystallogr C Struct Chem. 2024 Jun 1;80(Pt 6):239-253. doi: 10.1107/S2053229624004534. Epub 2024 May 22.
10
Studies on solvatomorphism of betulinic acid.桦木酸溶剂同构现象的研究。
J Pharm Sci. 2014 Sep;103(9):2696-2703. doi: 10.1002/jps.23853. Epub 2014 Jan 13.

本文引用的文献

1
What is isostructurality? Questions on the definition.什么是同构性?关于定义的问题。
IUCrJ. 2024 Jan 1;11(Pt 1):3-6. doi: 10.1107/S2052252523010436.
2
Characterization of a New Solvatomorph of Drospirenone by Thermogravimetry-Mass Spectrometry Combined with Other Solid-State Analysis Methods.通过热重-质谱联用及其他固态分析方法对屈螺酮一种新溶剂化物的表征
ACS Omega. 2020 Sep 24;5(39):25289-25296. doi: 10.1021/acsomega.0c03531. eCollection 2020 Oct 6.
3
The effective volumes of waters of crystallization: non-ionic pharmaceutical systems.
结晶水的有效体积:非离子药物体系
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2019 Oct 1;75(Pt 5):784-787. doi: 10.1107/S2052520619010436. Epub 2019 Aug 31.
4
Influence of ligand positional isomerism on the molecular and supramolecular structures of cobalt(II)-phenylimidazole complexes.配体位置异构对钴(II)-苯基咪唑配合物分子和超分子结构的影响。
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2019 Aug 1;75(Pt 4):599-610. doi: 10.1107/S205252061900636X. Epub 2019 Jun 14.
5
Isomorphism: 'molecular similarity to crystal structure similarity' in multicomponent forms of analgesic drugs tolfenamic and mefenamic acid.同构现象:在托芬那酸和甲芬那酸等多组分形式的镇痛药中“分子相似性与晶体结构相似性”
IUCrJ. 2020 Jan 7;7(Pt 2):173-183. doi: 10.1107/S205225251901604X. eCollection 2020 Mar 1.
6
: from visualization to analysis, design and prediction.从可视化到分析、设计与预测。
J Appl Crystallogr. 2020 Feb 1;53(Pt 1):226-235. doi: 10.1107/S1600576719014092.
7
validation ALERTS: what they mean and how to respond.验证警报:其含义及应对方法
Acta Crystallogr E Crystallogr Commun. 2020 Jan 1;76(Pt 1):1-11. doi: 10.1107/S2056989019016244.
8
Crystal Engineering: An Outlook for the Future.晶体工程:未来展望
Angew Chem Int Ed Engl. 2019 Mar 22;58(13):4100-4107. doi: 10.1002/anie.201811313. Epub 2019 Feb 27.
9
Solvent Effects on Growth, Crystallinity, and Surface Bonding of Ge Nanoparticles.溶剂对 Ge 纳米颗粒生长、结晶度和表面键合的影响。
Inorg Chem. 2018 May 7;57(9):5299-5306. doi: 10.1021/acs.inorgchem.8b00334. Epub 2018 Apr 19.
10
Solvatomorphism of 9,9'-[1,3,4-thiadiazole-2,5-diylbis(2,3-thiophendiyl-4,1-phenylene)]bis[9H-carbazole]: isostructurality, modularity and order-disorder theory.9,9'-[1,3,4-噻二唑-2,5-二基双(2,3-噻吩二基-4,1-亚苯基)]双[9H-咔唑]的溶剂同构现象:同构性、模块化与有序-无序理论
Acta Crystallogr B. 2012 Dec;68(Pt 6):667-76. doi: 10.1107/S0108768112039651. Epub 2012 Oct 23.